MELI vs UNH: Which Is the Better Buy?
Side-by-side comparison of MercadoLibre, Inc. and UnitedHealth Group Incorporated โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
MercadoLibre, Inc. ยท Consumer Cyclical
$1,635.15
+45.0% upside to fair value
Grade B
High Quality
VS
UnitedHealth Group Incorporated ยท Healthcare
$423.38
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH trades at a lower forward P/E
(27.2x).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
MELI |
UNH |
| Current Price |
$1,635.15 |
$423.38 |
| Fair Value Estimate |
$2,370.97 |
$613.90 |
| Upside to Fair Value |
+45.0%
|
+45.0%
|
| Market Cap |
$82.9B |
$384.5B |
| Forward P/E |
43.2x
|
27.2x
|
| EV / EBITDA |
27.0x
|
13.8x
|
| Price / Sales |
2.6x
|
0.8x
|
| Price / FCF |
7.7x
|
19.6x
|
| Revenue Growth YoY |
+49.0%
|
+0.4%
|
| Gross Margin |
43.9%
|
18.8%
|
| Operating Margin |
9.6%
|
4.2%
|
| Return on Equity |
29.6%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
12.92%
|
5.12%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
MercadoLibre is a leading Latin American e-commerce and fintech platform with a durable competitive moat driven by its integrated logistics and financial services stack. The company commands approximately 30 to 35 percent market share in e-commerce and over 30 percent in online payments in key markets like Brazil. It is founder-influenced with a long-tenured management team and reinvests heavily โฆ
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by aโฆ
Accumulation Zones
| Metric |
MELI |
UNH |
| Zone Low |
$1,778.23 |
$460.42 |
| Zone High |
$2,015.32 |
$521.81 |
| In Buy Zone? |
Yes
|
Yes
|